These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3931666

  • 1. A study of cell mediated and humoral immunity in haemophilia and related disorders.
    Moffat EH, Bloom AL, Jones J, Matthews N, Newcombe RG.
    Br J Haematol; 1985 Sep; 61(1):157-67. PubMed ID: 3931666
    [Abstract] [Full Text] [Related]

  • 2. Immunologic studies in asymptomatic hemophiliac patients.
    Frydecka I, Kowalewska B, Lesiecki A, Kuliczkowski K, Palakowska A, Polkowski A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Sep; 113(5):708-15. PubMed ID: 2435638
    [Abstract] [Full Text] [Related]

  • 3. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.
    Cuthbert RJ, Ludlam CA, Steel CM, Beatson D, Peutherer JF.
    Br J Haematol; 1992 Mar; 80(3):364-9. PubMed ID: 1581216
    [Abstract] [Full Text] [Related]

  • 4. AIDS surveillance in haemophilia.
    Daly HM, Palmer R, Scott GL, Lee G.
    Br J Haematol; 1985 Feb; 59(2):383-90. PubMed ID: 3918559
    [Abstract] [Full Text] [Related]

  • 5. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
    Carr R, Veitch SE, Edmond E, Peutherer JF, Prescott RJ, Steel CM, Ludlam CA.
    Lancet; 1984 Jun 30; 1(8392):1431-4. PubMed ID: 6145879
    [Abstract] [Full Text] [Related]

  • 6. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
    Lederman MM, Ratnoff OD, Schacter B, Shoger T.
    J Lab Clin Med; 1985 Aug 30; 106(2):197-204. PubMed ID: 2410523
    [Abstract] [Full Text] [Related]

  • 7. Immune complexes in hemophilia.
    Poskitt TR, Poskitt PK, Bean CA, Arkel YS.
    Am J Hematol; 1981 Sep 30; 11(2):147-52. PubMed ID: 6795922
    [Abstract] [Full Text] [Related]

  • 8. Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A.
    Kessler CM, Schulof RS, Alabaster O, Goldstein AL, Naylor PH, Phillips TM, Luban NL, Kelleher JF, Reaman GH.
    Br J Haematol; 1984 Oct 30; 58(2):325-36. PubMed ID: 6236839
    [Abstract] [Full Text] [Related]

  • 9. An immunologic evaluation of hemophiliac patients and their wives. Relationships to the acquired immunodeficiency syndrome.
    deShazo RD, Andes WA, Nordberg J, Newton J, Daul C, Bozelka B.
    Ann Intern Med; 1983 Aug 30; 99(2):159-64. PubMed ID: 6603807
    [Abstract] [Full Text] [Related]

  • 10. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul 15; 153(2):147-57. PubMed ID: 7600466
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.
    Blombäck M, Kjellman H, Schulman S, Egberg N, Böttiger B, Wiechel B.
    Infection; 1987 Jul 15; 15(4):248-52. PubMed ID: 3499399
    [Abstract] [Full Text] [Related]

  • 12. Circulating immune complexes in haemophilia and von Willebrand's disease.
    Passaleva A, Massai G, Morfini M, Longo G, Rossi Ferrini PL, Ricci M.
    Scand J Haematol; 1983 Nov 15; 31(5):466-74. PubMed ID: 6606214
    [Abstract] [Full Text] [Related]

  • 13. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M.
    Rinsho Byori; 2001 Oct 15; 49(10):1000-4. PubMed ID: 11769464
    [Abstract] [Full Text] [Related]

  • 14. Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates.
    Gorski A, Gjerset GF, Martin PJ, Counts RB, Hansen JA.
    Clin Immunol Immunopathol; 1986 Sep 15; 40(3):447-55. PubMed ID: 3089655
    [Abstract] [Full Text] [Related]

  • 15. Decreased helper/suppressor cell ratios after treatment with factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV, Lewis JH, Spero JA, Bontempo FA, Rabin BS.
    Am J Med; 1984 Feb 15; 76(2):206-10. PubMed ID: 6230009
    [Abstract] [Full Text] [Related]

  • 16. Abnormalities of lymphocyte subsets are correlated with concentrate consumption in asymptomatic Italian hemophiliacs treated with concentrates made from American plasma.
    Mannucci PM, Gringeri A, Ammassari M, Mari D.
    Am J Hematol; 1984 Aug 15; 17(2):167-76. PubMed ID: 6235744
    [Abstract] [Full Text] [Related]

  • 17. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E, Kessler CM, Directors of the Comprehensive Hemophilia Treatment Centers in Region III.
    Haemophilia; 2007 Nov 15; 13(6):685-96. PubMed ID: 17973844
    [Abstract] [Full Text] [Related]

  • 18. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
    Froebel KS, Madhok R, Forbes CD, Lennie SE, Lowe GD, Sturrock RD.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1091-3. PubMed ID: 6226334
    [Abstract] [Full Text] [Related]

  • 19. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K, Niessner H, Bettelheim P, Deutsch E, Fasching I, Fuhrmann M, Hinterberger W, Korninger C, Neumann E, Liszka K.
    Thromb Haemost; 1983 Aug 30; 50(2):552-6. PubMed ID: 6314582
    [Abstract] [Full Text] [Related]

  • 20. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL.
    JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.